TD Asset Management
WVE icon

TD Asset Management’s Wave Life Sciences WVE Stock Holding History

TD Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
194,026
-144,800
-43% -$960K ﹤0.01% 1070
2026
Q1 		$2.46M Buy
338,826
+86,666
+34% +$1.13M ﹤0.01% 923
2025
Q4 		$4.29M Buy
252,160
+109,752
+77% +$1.12M ﹤0.01% 827
2025
Q3 		$1.04M Sell
142,408
-37,200
-21% -$301K ﹤0.01% 1084
2025
Q2 		$1.17M Buy
179,608
+25,200
+16% +$166K ﹤0.01% 1040
2025
Q1 		$1.25M Sell
154,408
-161,798
-51% -$1.77M ﹤0.01% 1047
2024
Q4 		$3.91M Buy
316,206
+64,400
+26% +$860K ﹤0.01% 842
2024
Q3 		$2.09M Buy
251,806
+67,860
+37% +$406K ﹤0.01% 1021
2024
Q2 		$918K Sell
183,946
-68,000
-27% -$388K ﹤0.01% 1178
2024
Q1 		$1.55M Buy
251,946
+46,200
+22% +$231K ﹤0.01% 1084
2023
Q4 		$1.04M Buy
205,746
+43,054
+26% +$230K ﹤0.01% 1175
2023
Q3 		$935K Buy
+162,692
New +$743K ﹤0.01% 1160
2021
Q1 		– Sell
-51,234
Closed -$403K – 1550
2020
Q4 		$403K Buy
+51,234
New +$430K ﹤0.01% 1359

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

TD Asset Management's WVE Position: Q2 2026 in Review

TD Asset Management reduced its Wave Life Sciences (WVE) stake by 43% in Q2 2026, selling an estimated $960K and leaving 194,026 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

TD Asset Management first reported a position in WVE in Q4 2020 and has held it in 13 quarters since. The position peaked at $4.29M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • TD Asset Management held 194,026 shares of Wave Life Sciences worth $1.13M as of Q2 2026.
  • TD Asset Management sold 144,800 Wave Life Sciences shares in Q2 2026, an estimated $960K.
  • Wave Life Sciences made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1070 holding.
  • TD Asset Management first reported a position in Wave Life Sciences in Q4 2020 and has held it in 13 quarters since.
  • TD Asset Management's Wave Life Sciences position peaked at $4.29M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.